Project ALS is pleased to share that the FDA has approved the drug edaravone – the first approved ALS treatment in over 20 years.
Edaravone, a free radical scavenger, appears to react with nerve-damaging compounds generated as part of the disease process. After six months of treatment, on top of standard-of-care, data showed the intravenous drug reduced the rate of functional decline in patients by about a third.
Read more

Remembering Leigh Vierstra: Her Inspiring Words at Tables Turned on ALS in Madison
Remembering Leigh Vierstra: Her Inspiring Words at Tables Turned on ALS in Madison Three weeks ago, Project ALS had the honor of hosting Tables Turned